Latest Arthritis: Drugs news
FDA Approves First Interchangeable Biosimilar for Inflammatory Diseases
posted October 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pharmacovigilance Needed for Rheumatology Patients
posted September 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
Recommendations have been developed for pharmacovigilance in rheumatology, emphasizing the need for continued monitoring of new drugs, according to a position statement issued by the American College of Rheumatology.
Editor's Recommendations
Study IDs Real-World Reasons for Lemborexant Discontinuation 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
GLP-1 Receptor Agonists Tied to Increased Risk for Alopecia .jpg)
Health Consequences Vary by Chemo Regimen in Testicular Cancer Survivors 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Early Complications Common in Older Kidney Transplant Recipients .jpeg)
1997 to 2022 Saw Increase in Pediatric Hospitalizations With AKI 
Frailty Linked to Incident Cognitive Decline in Men With CKD Monthly Specialist Briefings
Stay Connected
